Efficacy of polymyxin B hemoperfusion in and beyond septic shock: is an "endotoxin severity score" needed?

Crit Care. 2018 Aug 17;22(1):205. doi: 10.1186/s13054-018-2093-y.

Authors

Patrick M Honore¹, David De Bels², Thierry Preseau³, Sebastien Redant², Herbert D Spapen⁴

Affiliations

¹ ICU Department, Centre Hospitalier Universitaire Brugmann, Place Van Gehuchtenplein 4, 1020, Brussels, Belgium. [email protected].
² ICU Department, Centre Hospitalier Universitaire Brugmann, Place Van Gehuchtenplein 4, 1020, Brussels, Belgium.
³ Emergency Department, Centre Hospitalier Universitaire Brugmann, Brussels, Belgium.
⁴ Universitair Ziekenhuis Brussel, VUB University, Brussels, Belgium.

No abstract available

Publication types

Letter
Comment

MeSH terms

Anti-Bacterial Agents
Cohort Studies
Endotoxins
Hemoperfusion*
Humans
Polymyxin B
Shock, Septic*

Substances

Anti-Bacterial Agents
Endotoxins
Polymyxin B